Indian pharma stocks: Macquarie Equity Research has initiated outperform ratings for Divi's Labs, Suven Pharma, Bluejet Healthcare, and Syngene. Among the 11 companies...
The Nifty-50 index has reported a subdued performance for the third straight quarter, posting a single-digit year-on-year (YoY) growth in profit after tax...
In a battered market retail investor confidence is faltering as heightened volatility slows active client additions and new demat account openings. Data from...